Evidence map›Paper›PMID 41963410›Full record

ArticleScientific reports2026

Enrichment of T: A→A: T substitutions in the TP53 gene in esophageal carcinoma with high Fusobacterium burden.

Tomomitsu Tahara, Takuya Shijimaya, Jumpei Yamazaki, Tsubasa Shimogama, Sanshiro Kobayashi, Naohiro Nakamura, Yu Takahashi, Takashi Tomiyama, Toshiro Fukui, Tomoyuki Shibata and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tomomitsu TaharaThird department of internal medicine, Kansai Medical University, Hirakata, Japan. tomomiccyu@yahoo.co.jp.
Takuya ShijimayaThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Jumpei YamazakiTranslational Research Unit, Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Tsubasa ShimogamaThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Sanshiro KobayashiThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Naohiro NakamuraThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Yu TakahashiThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Takashi TomiyamaThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Toshiro FukuiThird department of internal medicine, Kansai Medical University, Hirakata, Japan.
Tomoyuki ShibataDepartment of Gastroenterology, Fujita Health University School of Medicine, Toyoake, Japan.
Makoto NaganumaThird department of internal medicine, Kansai Medical University, Hirakata, Japan.

Funding

Japan Society for the Promotion of Science 22K08089
6 · The paper itself

Abstract

Exogenous lifestyle and environmental risk factors impact mutation burden in both benign and cancerous tissues. Moreover, interactions between the mucosa-associated microbiome and such genotoxic changes have been implicated in several cancer types. This study aimed to characterize the TP53 mutation spectrum in esophageal carcinoma (EC) with high amounts of Fusobacterium species. Quantitative PCR analysis of Pan-Fusobacterium species and Fusobacterium nucleatum was performed in 112 EC cases (89 squamous cell carcinomas [SCCs] and 23 adenocarcinomas). Results were correlated with TP53 mutation spectra and clinicopathological features. Both Pan-Fusobacterium species and F. nucleatum were significantly enriched in EC tissues compared with adjacent normal esophagus (both P < 0.001). The TP53 mutation spectrum in Pan-fusobacterium-high EC was characterized by a decrease in C: G→A: T and an increase in T: A→A: T substitutions (P < 0.001). Pan-fusobacterium-high EC was associated with male sex, tumors located in the upper or middle esophagus, and squamous cell histopathology. Cases of EC with detectable levels of Pan-Fusobacterium and F. nucleatum were also associated with more invasive tumors and more advanced cancer stages at diagnosis. These results suggest that EC with high numbers of Fusobacterium species was associated with a distinct mutation spectrum. Future studies should be conducted to investigate the mechanisms of how Fusobacterium species induce specific somatic mutations.

Indexed as

AdenocarcinomaCarcinoma, Squamous CellEsophageal NeoplasmsFusobacteriumFusobacterium InfectionsTumor Suppressor Protein p53AgedFemaleFusobacterium nucleatumHumansMaleMiddle AgedMutationTP53 protein, humanTumor Suppressor Protein p53Esophageal carcinomaFusobacterium speciesmutation spectrumTP53 mutation

Identifiers

PMID41963410
PMCPMC13199510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.